NCT02621736View on ClinicalTrials.gov

Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Nocturnal Enuresis
Interventions
OTHER

blood sampling

At 4 visits capillary blood sampling for copeptin measurement will be performed with each child.

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
collaborator

University Children's Hospital Basel

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT02621736 - Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN). | Biotech Hunter | Biotech Hunter